STAT3 and cancer: In conclusion, our data demonstrated that RT prevents against STAT3 excessive activation in skeletal muscle mediated by the overabundance of plasma IL-6 and muscle oxidative stress, a key role to attenuate cancer-induced muscle atrophy.